Why is the MHC so polymorphic?

Most of its diversity sits in the residues that form the peptide-binding groove, and selection that favours presenting a broad range of pathogen peptides is thought to maintain many alleles across a population.

Does carrying a disease-associated HLA allele mean a person will get that disease?

No. HLA-disease links are statistical associations measured across populations; most carriers of a risk allele do not develop the associated disease, and this entry is not a basis for individual risk prediction.

MHC Genetics, Polymorphism, and Disease Association

The MHC region of the human genome (the HLA complex on chromosome 6) is the most polymorphic part of the human genome, with thousands of alleles at its principal loci. This diversity is concentrated in the residues that line the peptide-binding groove, so different alleles present different sets of peptides. The inheritance, codominant expression, and strong linkage disequilibrium of HLA genes explain both their value in transplantation matching and their many associations with autoimmune and infectious diseases.

Definition

MHC polymorphism refers to the very large allelic diversity of the histocompatibility loci, concentrated in peptide-contacting residues, that is inherited as codominantly expressed haplotypes and underlies inter-individual differences in antigen presentation and in disease associations.

Scope

This topic covers the genomic organisation of the MHC, the sources and maintenance of its polymorphism, haplotypes and linkage disequilibrium, and the basis of HLA-disease associations. It is reference material on genetics and immunology and does not provide clinical risk estimates or guidance for individuals.

Core questions

How is the MHC region organised, and which loci carry the most polymorphism?
What evolutionary forces maintain such extreme allelic diversity?
How do linkage disequilibrium and haplotypes shape HLA inheritance?
Why are particular HLA alleles statistically associated with specific diseases?

Key concepts

HLA complex on chromosome 6
Allelic polymorphism concentrated in the peptide groove
Codominant expression
Haplotypes and linkage disequilibrium
Balancing selection
HLA-disease association
Transplantation matching

Key theories

Balancing selection of MHC diversity: The clustering of polymorphism in peptide-binding residues, together with population genetic patterns, is widely interpreted as the result of balancing selection (for example heterozygote advantage and frequency-dependent pathogen pressure) that maintains a broad repertoire of presentable peptides; this remains an active area of study.

Mechanisms

The classical MHC loci encode the class I (HLA-A, -B, -C) and class II (HLA-DR, -DQ, -DP) molecules, and their polymorphism is concentrated at the codons specifying peptide-groove residues, so different alleles bind different peptide motifs. Both parental haplotypes are expressed (codominance), widening the peptide repertoire an individual can present. Strong linkage disequilibrium across the region means specific allele combinations travel together as conserved haplotypes, which complicates pinpointing which gene drives an association. Statistical HLA-disease associations are thought to arise when particular alleles alter the peptide repertoire presented to T cells, biasing self-tolerance or pathogen recognition; the genomics review surveys these mechanisms and their interpretation.

Clinical relevance

HLA genetics underpins donor matching in transplantation and explains many documented disease associations and adverse-drug-reaction links. This entry summarises population- and gene-level relationships for educational purposes; it does not provide individual genetic-risk interpretation, typing recommendations, or clinical advice.

Epidemiology

Numerous HLA alleles show reproducible statistical associations with autoimmune, infectious, and other diseases, and the MHC is consistently among the strongest signals in genome-wide association studies of immune-related traits. These associations are population-level statistical patterns, not deterministic predictors for any individual.

Evidence & guidelines

The content reflects established population and molecular genetics summarised in peer-reviewed reviews and textbooks. Disease associations are reported as statistical findings; this entry does not constitute clinical guidance.

History

The MHC was first defined through transplantation genetics, then recognised as a single gene-dense, highly polymorphic region. As sequencing matured, the catalogue of HLA alleles grew into the thousands, and genome-wide association studies repeatedly identified the MHC as a leading locus for immune-mediated diseases. Interpretation has shifted from cataloguing associations toward understanding how allele-specific peptide presentation and regional linkage disequilibrium generate them.

Debates

What maintains the extreme polymorphism of the MHC?: Heterozygote advantage, frequency-dependent (pathogen-driven) selection, and mate-choice effects have all been proposed; their relative contributions remain debated, and disentangling them is complicated by the region's strong linkage disequilibrium.

Key figures

Jan Klein
John Trowsdale
Julian Knight

Seminal works

trowsdale-2013
klein-2000

Frequently asked questions

Why is the MHC so polymorphic?: Most of its diversity sits in the residues that form the peptide-binding groove, and selection that favours presenting a broad range of pathogen peptides is thought to maintain many alleles across a population.
Does carrying a disease-associated HLA allele mean a person will get that disease?: No. HLA-disease links are statistical associations measured across populations; most carriers of a risk allele do not develop the associated disease, and this entry is not a basis for individual risk prediction.